Send the following on WhatsApp
Continue to ChatStory : BioNTech to buy T-cell receptor facility and platform from Gilead Sciences #FinanceUSA #StockMarketNEWS Shares of BioNTech SE were down 2.4% in premarket trading on Monday after the company said https://munafa.org.in/story/1058/BioNTech-To-Buy-T-Cell-Receptor-Facility-And-Platform-From-Gilead-Sciences-FinanceUSA-StockMarketNEWS-Shares-Of-BioNTech-SE-Were-Down-2-4-In-Premarket-Trading-On-Monday-After-The-Company-Said/